Summary It is reported that arachidonic acid strongly induces the conformational change in vitro and transactivity of PPAR ␣ in colorectal cancer cell line Caco-2. In this study, we demonstrated that the induction of conformational change and transactivity of PPAR ␦ by arachidonic acid, as well as other polyunsaturated fatty acids, was considerably lower than that of PPAR ␣ . Mammalian two-hybrid assay showed that arachidonic acid enhanced binding of one of the coactivators, p300, to PPAR ␣ but not to PPAR ␦ . Additionally, arachidonic acid induced in vitro binding of both PPAR ␣ -RXR ␣ and PPAR ␦ -RXR ␣ heterodimers to several PPREs on CRBPII, L-FABP and ACO genes. Our results suggest that the lower transactivity of PPAR ␦ for arachidonic acid in Caco-2 cells, compared with PPAR ␣ , is associated with the binding activity of p300 to the receptor.
Recent studies have shown that fatty acid signaling is mediated by a nuclear receptor, the peroxisome proliferator-activated receptor (PPAR) ( 1 , 2 ) . To date, three subtypes of PPAR have been cloned in amphibians, rodents and humans: PPAR ␣ ( 3 , 4 ), PPAR ␦ (also called PPAR ␤ , NUC-1, or FAAR) ( 5 ), and PPAR ␥ ( 6 ). PPARs play key roles in different aspects of lipid metabolism and homeostasis. PPARs share a common binding specificity for the "DR1 type" element ( 7 ), which has been designated as the peroxisome proliferator-activated receptor response element (PPRE), since it enhances the transcription of the PPAR-target genes. Gene expression of the target genes for PPAR is thought to be differentially activated through the PPAR subtypes, which are activated by fatty acids or eicosanoids differentially recruited on the PPRE ( 7 -10 ). One of the main roles of PPAR ␣ is to activate fatty acid metabolism, such as ␤ -oxidation in the liver and other tissues. Our previous studies have demonstrated that PPAR ␣ is vital for expression of intestinal gene-related fatty acid/vitamin A absorption ( 11 , 12 ). A recent study suggests that polyunsaturated fatty acids of 18-20 carbon groups with 3-5 double bonds strongly induce PPAR ␣ transactivity, as determined by mammalian one-hybrid assay of colorectal cancer cell line Caco-2, which is known to be differentiated to intestine-like cells after over-confluency ( 13 ). Arachidonic acid is believed to be a strong activator of PPAR ␣ because it most strongly activates PPAR ␣ transactivity among polyunsaturated fatty acids, via its cis -element PPREs ( 10 , 13 ). However, the fatty acid reactivity of PPAR ␦ is still not well understood. Previous research has shown that PPAR ␦ has a dominant negative effect for PPAR ␣ ( 14 ). Additionally, our studies indicate that PPAR ␦ expression in the small intestine was inversely associated, whereas PPAR ␣ expression was positively correlated, with PPAR-target gene expression ( 11 , 12 ). Thus, we hypothesized that PPAR ␦ may have a dominant negative function for PPAR ␣ caused by lower reactivity for fatty acids. Whether or not fatty acids, including arachidonic acid, induce PPAR ␦ transactivity in any cell lines, including colorectal cancer cell lines, remains unclear.
Here, we examined the fatty acid-induced conformational change and fatty acid-induced transactivity of PPAR ␦ compared with PPAR ␣ in colorectal cancer cell line Caco-2. Furthermore, we examined whether arachidonic acid enhances the PPAR ␣ -or PPAR ␦ -binding to major coactivator p300 ( 15 -17 ) , which has histone acetyl-transferase activity and plays a critical role in recruiting transcriptional complexes ( 18 ) . Our results suggest that the lower transactivity, induced by arachidonic acid, of PPAR ␦ compared with PPAR ␣ in Caco-2 cells may be caused by p300 recruitment on the receptors.
MATERIALS AND METHODS

Materials.
Palmitic acid, oleic acid, linoleic acid, ␣ -linolenic acid, ␥ -linolenic acid, arachidonic acid, docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) and caprylic acid were purchased from Nakalai Tesque (Kyoto, Japan). Carbaprostacyclin (cPGI) was purchased from Cayman Chemical (Ann Arbor, MI, USA).
Differential protease sensitivity assay (DPSA).
35
Slabeled PPAR ␣ and PPAR ␦ were produced using a T7 Quick TNT in vitro transcription/translation kit (Promega, Madison, WI, USA), as described previously ( 11 ). Reactions for differential protease sensitivity assay (DPSA) were carried out in a final volume of 10 L in buffer containing 20 m M Hepes, pH 7.7, 75 m M KCl, 2.5 m M MgCl 2 , 2 m M DTT, 0.1% NP-40, and 7.5% glycerol.
S-labeled PPARs were incubated in the absence or presence of 40 M of various fatty acids or a synthetic PPAR ligand cPGI for 20 min at room temperature. After this initial incubation period, 1.0 g of chymotrypsin (sequence grade, Roche Applied Science, IN, USA) was added and incubated for 20 min at room temperature to allow digestion of the PPAR ␣ and PPAR ␦ proteins. The reactions were terminated by addition of an equal volume of stop solution (6% SDS, 22.4% glycerol, 0.02% bromophenol blue, 10% mercaptoethanol and 140 m M Tris-HCl, pH 6.8), and immediate boiling for 3 min. Then, the digested products were resolved on SDS-PAGE with 14% acrylamide gels. The gels were fixed with 10% acetic acid and 20% methanol, dried under vacuum, and exposed to an image plate (Fuji Film, Tokyo, Japan) for 12 h and visualized by BAS2000 imaging analyzer (Fuji Film).
Cell culture and transactivation assay. Caco-2 cells from the American Type Culture Collection were seeded at 2.5 ϫ 10 4 cell/well in 48-well cell culture plates and cultured in Dulbecco's modified eagle medium (DMEM) containing 10% fetal calf serum, 2 m M glutamine, 20 m M Hepes, 50 U/mL penicillin and 50 g/mL streptomycin sulfate at 37˚C in a humidified atmosphere of 5% CO 2 . After 72 h, transfections were performed using Tfx-50 transfection reagent (Promega) according to manufacturer's instructions. Transfection reagent for mammalian one-hybrid assays for determination of transactivity of PPARs ( Fig. 2 ) contained 1.8 L Tfx-50, 5 ng pRL-SV40 (Promega), 0.1 g pG5-Luc (Promega), and 0.1 g of either pBIND/rat PPAR ␣ -ligand-binding domain (LBD), pBIND/rat PPAR ␦ -LBD ( 13 ) or pBIND empty expression vector (Promega), in each well. In the mammalian two-hybrid assays for determination of binding activity in Caco-2 cells of PPARs to p300 (Fig.  2) , transfection mixes for each well contained 1.8 L Tfx-50, 2 ng pRL-SV40, 0.1 g pG5-Luc, and 0.1 g of either pBIND-PPAR ␣ -LBD, pBIND-PPAR ␦ -LBD or pBIND expression vector and 0.1 g of either pACTp300 ( 16 ) or pACT (Promega) empty expression vector. Cells were incubated in the transfection mixture for 2 h at 37˚C in a humidified atmosphere of 5% CO 2 . The cells were then incubated for 48 h in standard medium supplemented with charcoal/dextran-treated 10% fetal bovine serum in the absence or presence of 10 M fatty acids and synthetic ligands. The firefly luciferase and renilla luciferase activities were determined by a dualluciferase reporter assay system (Promega).
Electrophoretic mobility shift assay (EMSA) . PPAR ␣ , PPAR ␦ and retinoid X receptor ␣ (RXR ␣ ) were produced using a T7 Quick TNT in vitro transcription/ translation kit (Promega) as described previously ( 11 ). Parallel translations of these nuclear receptors were carried out in the presence of [ 35 S]methionine. The assay conditions for EMSA were the same as described previously ( 12 ). The sequence of the oligonucleotide probe was as follows (only one strand is shown with basal motifs underlined); CRBPII-RXRE, CTGCTGTCACAGGTCACAGGTCACAG GTCACAGTTCATTTTC; CRBPII-RE3, CGATAACAGAG TCAAAGGTCATAAGC; L-FABP, CTCCTCAAATATAGGC CATAGGCCATAGGTCAGTGT; AOX, AGCTTGGGGACC AGGACAAAGGTCAGGATC-3 ¢ .
RESULTS AND DISCUSSION
First, we performed DPSA to examine whether fatty acids induce conformational changes in PPAR ␦ in vitro. Figures 1A and 1B show that (Fig. 1B) were protected from protease digestion by cPGI, a ligand for both PPAR␣ and PPAR␦. This result indicates that cPGI induces conformational change of PPAR␦ as well as PPAR␣. Additionally, all fatty acids we tested induced PPAR␣ conformational changes. In particular, ␣-linoleic acid, ␥-linoleic acid, arachidonic acid (n-6), EPA and DHA, the typical polyunsaturated fatty acids, most strongly induced PPAR␣ conformational change (Fig. 1A) , which is consistent with our previous report (13). However, the fatty acids we tested did not induce conformational change of PPAR␦ (Fig. 1B) . Because many previous studies have shown that conformational changes of nuclear receptors induced by their ligands are associated with transactivation (6), it is speculated that the transactivity of PPAR␦ induced by fatty acids is lower than that of PPAR␣.
To explore this hypothesis, we conducted co-transfection with chimeric receptors composed of GAL4-DBD and PPAR-LBD along with a GAL4-responsive reporter gene. This GAL4-PPAR chimera reporter assay (onehybrid assay) enables us to evaluate the DNA bindingindependent transactivity in a quantitative manner (13). Previously, we have reported that the transactivity of PPAR␣ was induced by polyunsaturated fatty acids of 18-20 carbon groups with 3-5 double bonds in Caco-2 cells (13). We have confirmed that ␣-linoleic acid (C18, double bond; 3), ␥-linoleic acid (C18, double bond; 3), arachidonic acid (C20, double bond; 4) and EPA (C20, double bond; 4) induced PPAR␣ transactivity by 14.1-, 16.6-, 29.2-, and 18.6-fold, respectively (Fig. 2) . In particular, arachidonic acid strongly induced transactivity of PPAR␣. Transactivity of PPAR␦ induced by palmitic acid, oleic acid, linoleic acid, ␣-linoleic acid, ␥-linoleic acid, arachidonic acid and EPA, relative to DMSO only, was 1.6-, 1.6-, 1.9-, 4.0-, 4.9-, 9.2-, and 4.3-fold, respectively (Fig. 2) . Interestingly, transactivity of PPAR␦ induced by each fatty acid, including arachidonic acid, was 2-4 fold lower than that of PPAR␣, although cPGI similarly induced transactivity of both PPAR␦ and PPAR␣ (Fig. 2) . These results indicate that the transactivity of PPAR␦ induced by fatty acids, including arachidonic acid, is lower than that of PPAR␣ in Caco-2 cells.
Recent studies indicate that differences in the transactivity of nuclear receptors induced by their ligands is caused by differences in the binding to coactivators (15, 19) , known to intermediate the signal of nuclear receptor binding of the cis-element to transcriptional complexes (20) . Our previous studies have revealed that one of the coactivators, p300, is expressed in the rat small intestine and strongly activates PPAR signaling in Caco-2 (16, 21) . We speculated that the lower transactivity of PPAR␦ induced by fatty acids compared with that of PPAR␣ in Caco-2 cells (Fig. 2) might be caused by the difference in binding activity of coactivator p300 to the receptors. Previous studies have shown that cPGI enhances p300 binding to the PPAR␣ (71.1-fold) or PPAR␦ (28.5-fold) in Caco-2 cells by mammalian twohybrid assay (16) . Thus, we examined whether arachidonic acid, which most activated the transcriptional recruiting activity of PPAR␣ (Fig. 2) , and its precursor linoleic acid, induces p300 binding of PPAR␣ and PPAR␦ in Caco-2 cells. Interestingly, arachidonic acid enhanced the binding of PPAR␣ to p300, but not PPAR␦, in Caco-2 cells (Fig. 3) . It should be noted that linoleic acid tended to equally enhance the binding of PPAR␣ to p300; however the result was not significant. The one-hybrid assay evaluates recruiting activity of endogenous transcriptional complex, whereas the twohybrid assay evaluates the protein-protein binding activity. This may provide a reason why PPAR␣ transactivity is induced by arachidonic acid rather than linoleic acid in one-hybrid assay, and may be due to recruitment of other coactivators as well as p300 on PPAR␣. These results indicate that arachidonic acid may enhance transactivity of PPAR␣ but not PPAR␦, by regulating p300 binding activity to the receptors in Caco-2 cells. Finally, we examined whether arachidonic acid and linoleic acid induce DNA binding activity of PPAR␣-RXR␣ or PPAR␦-RXR␣ heterodimer on PPREs. Previous studies revealed that fatty acids enhance the binding of PPAR␣-RXR␣ heterodimer to PPRE (13, 22) . Figure 4 shows that arachidonic acid enhanced the binding of PPAR␦-RXR␣ heterodimer as well as PPAR␣-RXR␣ to PPREs on intestinal PPAR-target genes such as CRBPII (RXRE, RE3), L-FABP, and acyl-CoA oxidase (ACO). Linoleic acid also enhanced the binding of both PPAR␦-RXR␣ and PPAR␣-RXR␣ heterodimers to PPREs on L-FABP and ACO. This result indicates that arachidonic acid and linoleic acid both induce the binding of both PPAR␦-RXR␣ and PPAR␣-RXR␣ heterodimer to PPREs. A recent study indicated that expression of the PPAR␣ gene as well as PPAR target genes such as CRBPII, L-FABP, and ACO in the small intestine are induced by feeding rats a high fat diet, whereas expression of PPAR␦ gene decreased (11). It seems that PPAR␦ has a function for repressing intestinal PPAR-target gene expression by regulating PPAR␣ transactivity. Indeed, PPAR␦ repressed PPAR␣ activity in the presence of PPAR␣ strong activator WY14,643 in CV-1 cells (14) . Whether or not PPAR␦ represses arachidonic acid-induced PPAR␣ transactivity is yet to be investigated. Our results, in combination with previous observations, suggest that PPAR␦ may have a week dominant negative effect on PPAR␣ in the small intestine. Further investigation on PPAR␦ repression of arachidonic acid-induced PPAR␣ transactivity in Caco-2 cells is needed.
It is still unclear whether fatty acids, including arachidonic acids, bind PPAR␦ even though we showed that arachidonic acid enhances PPAR␦-RXR␣ heterodimer binding to PPREs. It has already been reported that arachidonic acid binds PPAR␦ as well as PPAR␣ in vitro (9). Investigations comparing PPAR␣ and PPAR␦ binding activity for a broad range of fatty acids in vitro are required. In addition, information regarding whether or not fatty acids induce in vivo binding of PPARs-RXR heterodimer on the PPREs, and p300 binding to PPARs in Caco-2 cells is still needed.
In conclusion, we have demonstrated that the transactivity and p300-binding activity of PPAR␦ induced by arachidonic acid in Caco-2 cells were lower than that of PPAR␣. Further studies of Caco-2 cells are needed to investigate whether fatty acids enhance transactivity of another subtype, PPAR␥, which is also expressed in the small intestine (23) . The resulting heterodimers were detected by electrophoretic mobility shift assays, which were performed using 32 P-labeled oligonucleotides representing PPRE. The asterisks indicate non-specific binding complex.
